Senior Vice President, Public Affairs, Alkermes
Jeffrey A. Winton is the Senior Vice President of Public Affairs for Dublin-based biopharmaceutical company Alkermes (NASDAQ:ALKS). He is responsible for building a new global public affairs function encompassing corporate, product and internal communications, digital/social media, corporate brand and reputation, patient engagement, corporate social responsibility and corporate citizenship. Prior to joining Alkermes in the fall of 2018, Jeff was Senior Vice President, Corporate Affairs and Chief Communications Officer at Tokyo-based global biopharmaceutical company, Astellas Pharma. Prior to joining Astellas, Jeff served as Vice President and Head of Global Communications at the Fortune 125 Eli Lilly and Company. Prior to Lilly, Jeff was Managing Partner of West Mill Consulting LLC. He has also served as Vice President and Head of Communications at Schering-Plough (acquired by Merck) and Pharmacia (acquired by Pfizer). During his three plus decades in the business, Jeff has also worked for prominent public relations and advertising agencies in NYC and the Midwest. Jeff graduated with distinction from Cornell University with a bachelor’s degree from the College of Agriculture and Life Sciences and he is currently serving his second term on the Cornell University College of Agriculture and Life Sciences Dean’s Advisory Council. In addition, he has completed several graduate-level courses at Union Theological Seminary in NYC. Jeff is active in a number of professional organizations, including Public Relations Society of America (PRSA), PRSA Health Academy, The Seminar, and Arthur W. Page Society. Jeff has received a number of prestigious industry awards including the 2017 Plank Center John Koten Corporate Mentor Award, the first annual PRSA Health Academy Excellence in Public Relations Award, and the 2015 Chicago Skyline PRSA Professional of the Year Award.